# Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

> **NCT06344130** · PHASE1 · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 28 (estimated)

## Conditions studied

- Astrocytoma
- Glioma
- Recurrent Glioblastoma

## Interventions

- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT06344130
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344130, "Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06344130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*